Skip to content

Very low rate of liver problems seen with Kaletra

CD4 percentage could help decide when to start treatment

HAART is not reducing risk of anal cancer in gay men

Death rate falls in drug users after introduction of effective HIV treatment

NNRTIs have a greater risk of resistance than PIs when used in regimens after treatment break

Risk of peripheral neuropathy five times higher for common genetic group

US men's study finds cumulative NRTI use, but not PIs or NNRTIs, associated with insulin resistance

Hepatitis C co-infection blunts response to antiretroviral therapy

South Africa: Erratic infant formula supply puts PMTCT at risk